文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

静脉血栓栓塞性疾病的临床流行病学:一项机构登记研究。

Clinical epidemiology of venous thromboembolic disease: An institutional registry.

作者信息

AlSheef Mohammed, Alshammari Fouad Taiwilaa, Alhawish Mashel Khalid, Alghamdi Abduljabar Ghazi, Alqudhybi Abdullah Fahad, Abu-Shaheen Amani

机构信息

King Fahad Medical City, Riyadh, Saudi Arabia.

Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.

出版信息

Front Cardiovasc Med. 2022 Jul 22;9:928094. doi: 10.3389/fcvm.2022.928094. eCollection 2022.


DOI:10.3389/fcvm.2022.928094
PMID:35958419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9361013/
Abstract

INTRODUCTION: Venous thromboembolism (VTE) is a major health concern, with an annual incidence of ~1 in 1,000. The epidemiology of VTE in Saudi Arabia has not been adequately described yet. Therefore, this study aimed to assess the clinical characteristics, risk factors, diagnostic methods, management, and clinical outcomes of patients with VTE. METHODS: This study was based on a VTE registry created over ten years at King Fahad Medical City (KFMC) in Riyadh, Saudi Arabia. All adult inpatients and outpatients referred to the thrombosis unit of the KFMC with clinically suspected VTE including pulmonary embolism (PE) and deep vein thrombosis (DVT) were enrolled. Data were collected using a standardized case report form, which included demographic and clinical characteristics, risk factors, diagnostic methods, management, and outcomes. RESULTS: A total of 1,008 patients were recruited. Most patients were women (73.2%), and more than half of all patients had unprovoked VTE (58%). Among the provoked cases, the most frequent cause was surgery (29.8%), followed by hospitalization (24.2%). There was a significant statistical association between provoked status and sex, family history of VTE, smoking, recent hospitalization within 3 months for a medical condition, the site of VTE, and underlying peripheral vascular disease and varicose veins (all < 0.05). The majority (88.3%) of patients with deep vein thrombosis was hospitalized for ≤3 days ( = 433, 79.9%), while fewer than half of the patients with PE needed hospitalization (45.3%). Thrombolytic therapy was administered to 14.1% ( = 142) of patients, and catheter-directed thrombolysis was performed in 1.0% ( = 10) of patients. The odds of mortality for provoked VTE were 3.20 times higher than those of unprovoked VTE [2.12-4.83; -value < 0.001]. CONCLUSION: Unprovoked VTE was more common than provoked VTE in the Saudi Arabian cohort, implying hereditary predisposition. Furthermore, male sex, family history of VTE, prior history of VTE, type of VTE, underlying obesity, history of trauma, surgery, hospitalization, pregnancy, and 3-6 months of anticoagulation therapy were the most critical risk factors for VTE recurrence. The treatment patterns and clinical results were comparable to those reported in the literature.

摘要

引言:静脉血栓栓塞症(VTE)是一个主要的健康问题,年发病率约为千分之一。沙特阿拉伯VTE的流行病学尚未得到充分描述。因此,本研究旨在评估VTE患者的临床特征、危险因素、诊断方法、治疗及临床结局。 方法:本研究基于沙特阿拉伯利雅得法赫德国王医疗城(KFMC)建立超过十年的VTE登记册。所有因临床疑似VTE(包括肺栓塞(PE)和深静脉血栓形成(DVT))转诊至KFMC血栓科的成年住院和门诊患者均被纳入。使用标准化病例报告表收集数据,该表包括人口统计学和临床特征、危险因素、诊断方法、治疗及结局。 结果:共招募了1008例患者。大多数患者为女性(73.2%),超过半数患者发生不明原因的VTE(58%)。在有诱因的病例中,最常见的原因是手术(29.8%),其次是住院(24.2%)。诱因状态与性别、VTE家族史、吸烟、3个月内因疾病近期住院、VTE部位以及潜在的外周血管疾病和静脉曲张之间存在显著统计学关联(均P<0.05)。大多数(88.3%)深静脉血栓形成患者住院时间≤3天(n = 433,79.9%),而需要住院的肺栓塞患者不到半数(45.3%)。14.1%(n = 142)的患者接受了溶栓治疗,1.0%(n = 10)的患者进行了导管定向溶栓。有诱因的VTE患者的死亡几率比不明原因的VTE高3.20倍[2.12 - 4.83;P值<0.001]。 结论:在沙特阿拉伯队列中,不明原因的VTE比有诱因的VTE更常见,这意味着存在遗传易感性。此外,男性、VTE家族史、VTE既往史、VTE类型、潜在肥胖、创伤史既往史、手术、住院、妊娠以及3 - 6个月的抗凝治疗是VTE复发的最关键危险因素。治疗模式和临床结果与文献报道相当。

相似文献

[1]
Clinical epidemiology of venous thromboembolic disease: An institutional registry.

Front Cardiovasc Med. 2022-7-22

[2]
High Prevalence and Mortality Associated with Upper Extremity Deep Venous Thrombosis in Hospitalized Patients at a Tertiary Care Center.

Ann Vasc Surg. 2020-5

[3]
Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study.

Curr Med Res Opin. 2018-6-20

[4]
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.

Cochrane Database Syst Rev. 2015-3-6

[5]
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.

Cochrane Database Syst Rev. 2017-8-23

[6]
Clinical presentation of venous thromboembolism in inflammatory bowel disease.

J Crohns Colitis. 2012-11-3

[7]
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism.

J Thromb Thrombolysis. 2020-5

[8]
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Haematologica. 2007-2

[9]
Exploring the Clinical Efficacy of Venous Thromboembolism Management in Saudi Arabian Hospitals: An Insight into Patient Outcomes.

J Pers Med. 2023-3-31

[10]
Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.

J Vasc Surg Venous Lymphat Disord. 2019-1-16

引用本文的文献

[1]
Epidemiology of Vascular Thrombosis in the Eastern Province of Saudi Arabia: A Single Center Study and Comparison with National Data.

J Epidemiol Glob Health. 2025-2-17

[2]
Incidence and Clinical Features of Venous Thromboembolism in Inpatients with Mental Illness.

Clin Appl Thromb Hemost. 2023

本文引用的文献

[1]
Genetically predicted obesity and risk of deep vein thrombosis.

Thromb Res. 2021-11

[2]
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.

Res Pract Thromb Haemost. 2021-2-20

[3]
Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism.

Int J Cardiol. 2021-5-15

[4]
Association between congenital thrombophilia and outcomes in pulmonary embolism patients.

Blood Adv. 2020-12-8

[5]
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

Blood Adv. 2020-10-13

[6]
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Eur Heart J. 2020-1-21

[7]
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.

J Thromb Haemost. 2019-7-23

[8]
Risk of recurrent venous thromboembolism according to baseline risk factor profiles.

Blood Adv. 2018-4-10

[9]
The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry.

Thromb Haemost. 2017-6-27

[10]
Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Semin Thromb Hemost. 2016-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索